ALPS Biotech Co., Ltd. has formally signed the Go Incubation Board counseling agreement with the Taipei Exchange (TPEx), joining the public joint counseling program under the Go Incubation Board Regulations. The signing was witnessed by TPEx General Manager Chen Li-Ching. The company will follow TPEx counseling to strengthen corporate governance and financial transparency.
more
In the first episode of Rocking Life, Dr. Tzu-Wen Lin, Deputy Director of R&D at ALPS Biotech, and Mr. Lin Hsiu-Cheng, Chairman of the Taiwan Spinocerebellar Ataxia Association (TSCAA), discussed the origins of the Antrodia-ataxia partnership, the shift from droplet pills to clinical trial capsules, triterpenoid quality control, and the development progress of botanical drug AC04.
more
ALPS Biotech held its annual shareholders' meeting on June 25, 2026, chaired by Chairman Shui-Tien Chen. The company reported its 2025 R&D progress across three pillars: the AC04 botanical drug clinical study, the launch of its oral protective gel, and in-house biomaterials production processes.
more
ALPS Biotech is advancing next-generation wound protection with AL-BM002, a plant-derived adhesion material designed to form a fast-drying, clear, flexible and breathable protective film.
more
Sustainable chemistry is driving innovation towards greener solutions. Notable advancements include HMF, FDCA, FDME, and PEF, which exemplify the potential of using nature's resources for a more sustainable economy.
more
Antrodia Cinnamomea, a Miracle Fungus Endemic to Taiwan
more
Cinnamomum kanehirae that is endemic to Taiwan is a national treasure-level protected plant species. However, there are still unethical businesses illegally collecting and transporting them so that they can be grown in Mainland China. Mainland China has even claimed that Antrodia cinnamomea belongs to them. Shui-Tein Chen, chairman of the Antrodia Cinnamomea Association of Taiwan National Treasure, believes that they are obliged to “authenticate” Cinnamomum kanehirae by using the company’s technology to create an exclusive database for the identification of Cinnamomum kanehirae.
more
With internationally reputed biotech Research & Development competence, Taiwan established the National Biotechnology Research Park and recruited those with new-drug development capacity and Dr. Shui-Tein Chen is one of them. Retiring from the Academia Sinica five years ago, Dr. Chen began his additional engagements in new-drug development and talent development with his pension as the startup founding.
more
Add：12 F.-5, No. 50, Linsen N. Rd., Zhongshan Dist., Taipei City 104404, Taiwan (R.O.C.)
Tel:+886-2-27887626
Fax：+886-2-23788043
